Syntheses of some 4-anilinoquinazoline derivatives

被引:38
作者
Rocco, SA [1 ]
Barbarini, JE [1 ]
Rittner, R [1 ]
机构
[1] UNICAMP, Inst Quim, Phys Organ Chem Lab, BR-13084971 Campinas, SP, Brazil
来源
SYNTHESIS-STUTTGART | 2004年 / 03期
关键词
4-anilinoquinazolines; quinazolinones; ATP-inhibitors;
D O I
10.1055/s-2004-815949
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Some 4-N-(3'- or 4'-substituted-phenyl)amino-6,7-dimethoxyquinazolines and the corresponding unsubstituted compounds were synthesized from 2-amino-4,5-dimethoxybenzoic acid and the appropriate substituted anilines. Other related quinazolines or their synthetic intermediates were also obtained. A large number of the described quinazolines are new compounds, while the remaining were prepared by a more efficient procedure. The main goal for the synthesis of these compounds comes from the fact that the 4-anilinoquinazoline pharmacophore is an important unit, which is found among the ATP-competitive inhibitors of several protein kinase enzymes.
引用
收藏
页码:429 / 435
页数:7
相关论文
共 24 条
  • [1] ZD1839 ('Iressa')1,2 as an anticancer agent
    Baselga, J
    Averbuch, SD
    [J]. DRUGS, 2000, 60 (Suppl 1) : 33 - 40
  • [2] Tyrosine kinase inhibitors .8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor
    Bridges, AJ
    Zhou, H
    Cody, DR
    Rewcastle, GW
    McMichael, A
    Showalter, HDH
    Fry, DW
    Kraker, AJ
    Denny, WA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 267 - 276
  • [3] Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents
    Ciardiello, F
    [J]. DRUGS, 2000, 60 (Suppl 1) : 25 - 32
  • [4] ACYLANTHRANILS .3. INFLUENCE OF RING SUBSTITUENTS ON REACTIVITY AND SELECTIVITY IN REACTION OF ACYLANTHRANILS WITH AMINES
    ERREDE, LA
    OIEN, HT
    YARIAN, DR
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1977, 42 (01) : 12 - 18
  • [5] FRANCHINI K, COMMUNICATION
  • [6] Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: Progression from reversible to irreversible inhibitors
    Fry, DW
    [J]. PHARMACOLOGY & THERAPEUTICS, 1999, 82 (2-3) : 207 - 218
  • [7] Recent advances in tyrosine kinase inhibitors
    Fry, DW
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 : 151 - 160
  • [8] A SPECIFIC INHIBITOR OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE
    FRY, DW
    KRAKER, AJ
    MCMICHAEL, A
    AMBROSO, LA
    NELSON, JM
    LEOPOLD, WR
    CONNERS, RW
    BRIDGES, AJ
    [J]. SCIENCE, 1994, 265 (5175) : 1093 - 1095
  • [9] GIRGIS NS, 1986, CHEM SCRIPTA, V26, P617
  • [10] Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors
    Hennequin, LF
    Thomas, AP
    Johnstone, C
    Stokes, ESE
    Plé, PA
    Lohmann, JJM
    Ogilvie, DJ
    Dukes, M
    Wedge, SR
    Curwen, JO
    Kendrew, J
    Lambert-van der Brempt, C
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) : 5369 - 5389